ALNY

UNDERPERFORM

Alnylam Pharmaceuticals, Inc. · Healthcare

$327.28+1.87%LAST CLOSE

24H+1.87%

1W+2.64%

1M+2.14%

1Y+45.90%

Live Chart · ALNY

1DNY TIME

BOGA AI Daily Brief

Confidence

23%

Sentiment

Bullish

Share Analysis

BOGA Master Score

22.6

High conviction score

BOGA AI Model Projection

Strategic Observation Zone$325.64 - $328.92

Projected Growth Objective$355.04 - $380.40

Model Invalidation Level$288.74 - $303.94

Risk/Reward1.5:1

AD-S2 · 300×250 Sidebar

Technical Indicators

RSI (14)

51.9

Neutral

MACD

1.486

NEUTRAL

RVOL

0.87x

Normal

Trends

DOWN

EMA Stack

Bearish

STABLE

BB Squeeze

LOW

MONITOR

Fundamentals & Margins

Market Cap

$0.04T

P/E Ratio

vs Sector: 25.0730915

139.2681

FCF Yield

0.3%

Gross Margin

81.6%

Operating Margin

12.0%

Net Margin

8.4%

Sector Context

Benchmarked against

XLV

5D Performance

+1.3%

ALNY is currently ranked in the top 20% of its sector based on BOGA Master Scores. It has outperformed XLV by 4.2% over the last 30 trading days.

Insider Activity (90D)

Transaction	Shares	Net Direction
Buys	0	SELL
Sells	22	SELL

Last Transaction: SELL 3910 shares

Score Categories

Recent Analysis & News

Related Stocks in Healthcare

EXEL

-2.64%

ELV

+0.51%

HOLX

+0.00%

BMY

-1.08%

CVS

+0.03%